Tesamorelin (10mg)

Tesamorelin — 10mg | Research Grade | Australia

Tesamorelin is a synthetic 44 amino acid analogue of human growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoic acid group at the N-terminus to resist enzymatic degradation by DPP-4 and extend its active half-life. It is the only GHRH analogue to have received FDA approval — granted in 2010 under the brand name Egrifta — making it the most clinically validated GHRH peptide available in the research literature. Unlike direct growth hormone administration, tesamorelin stimulates the body's own pulsatile GH secretion, preserving natural feedback regulation. Buy Tesamorelin in Australia from Austides — research-grade, third-party tested, domestically dispatched.

Research Applications

• Examined in Phase 3 randomised controlled trials for its effects on visceral adipose tissue (VAT) reduction via GH-driven lipolysis, with researchers observing 15–18% VAT reduction over 26 weeks compared to placebo

• Studied for its effects on pulsatile GH and IGF-1 secretion via pituitary stimulation in preclinical and clinical research settings

• Investigated in clinical trials for its influence on lipid profiles, with researchers observing reductions in triglycerides alongside body composition changes

• Examined in research settings for its anabolic downstream effects via IGF-1 and influence on lean mass preservation parameters

• Subject of emerging research into cognitive function parameters in older research populations via IGF-1 mediated pathways

Product Specifications

Austides Standard

All Austides peptides are third-party tested for purity and potency. Domestically dispatched from Australia with discrete, secure packaging and cold-chain integrity maintained throughout.

For research purposes only. Not for human consumption, therapeutic use, or self-administration. This product is not approved by the TGA for any therapeutic application.